Fundz

Mantra Bio, Inc. reported raising $30.1 Million in an initial SEC Form D filing, from an offering of $30.1 Million

PRIVATEAug 12, 2020

Amount Raised

$30.1 Million

$30.1 Million sold, per SEC Form D (first sale Aug 12, 2020)

Round Type

Venture

San FranciscoManufacturingBiotechnologyArtificial IntelligenceTherapeutics

Quick answer

Mantra Bio raised $30.1 Million in a funding round, dated August 12, 2020. Mantra Bio is based in San Francisco, California, United States.

How much did Mantra Bio raise?
Mantra Bio raised $30.1 Million in a funding round on August 12, 2020.
What does Mantra Bio do?
Mantra Bio is developing next generation, targeted therapeutics based on its proprietary exosome engineering platform, REVEAL™.
Where is Mantra Bio based and how big is it?
Mantra Bio is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Manufacturing around the same time

Companies in the same sectors as Mantra Bio that raised within 45 days of this round, from Fundz verified event records.

  • Recursion Pharmaceuticals raised $236M on September 15, 2020.
  • Azora Therapeutics, Inc. (DE) raised $500K on September 25, 2020.
  • Azitra raised $17M on September 24, 2020.
  • Asceneuron raised $85M (Series C) on September 23, 2020.
  • Libra Therapeutics raised $29M (Series A) on September 23, 2020.
  • LAVA Therapeutics raised $83M (Series C) on September 17, 2020.

Who to call at Mantra Bio, and when

A new round usually means Mantra Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mantra Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mantra Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mantra Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mantra Bio

Location

455 MISSION BAY BLVD SOUTH

San Francisco, California, United States

About

Mantra Bio is developing next generation, targeted therapeutics based on its proprietary exosome engineering platform, REVEAL™. The REVEAL™ platform, which integrates computational biology and bench lab automation, leverages the diversity of exosomes to enable the rational design of therapeutics directed at a wide range of tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process and related technologies to ensure this new class of therapeutics can be reproducibly made at high purity, consistency, and yield. The company's initial pipeline includes engineered exosome therapeutics in the areas of ophthalmology and infectious diseases. Investors include 8VC, Viking Global Investors, Samsung Securities, BoxGroup, Allen & Company LLC, and Illumina. Learn more about Mantra Bio at www.mantrabio.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mantra Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mantra Bio's next move

See what Strategic adds

Mantra Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.